Nitrite production in mouse 3T3 fibroblasts by bleomycin-stimulated peripheral blood mononuclear cell factors

Clinical and Experimental Rheumatology

Volumn 17, Issue 3, 1999, Pages 343-346

  Yamamoto, Toshiyuki ^a   Katayama, I ^b   Nishioka, K ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bleomycin; Fibroblasts; Nitric oxide; Peripheral blood mononuclear cells; Systemic sclerosis

Indexed keywords

BLEOMYCIN; CYTOKINE; GROWTH FACTOR; INTERLEUKIN 1BETA; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL GROWTH; CELL STIMULATION; CELL STRAIN 3T3; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; FIBROBLAST; FIBROSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

EID: 0032994879     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. COOK HT, CATTELL Y: Role of nitric oxide in immune-mediated diseases. Clin Sci 1996; 91: 375-84.
2. MONCADA S, HIGGS A: The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-12.
3. YAMAMOTO T, KATAYAMA I, NISHIOKA K: Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis. J Rheumatol 1998; 25: 314-7.
4. SCHAFFER MR, TANTRY U, GROSS SS, WASSERKRUG HL, BARBUL A: Nitric oxide regulates wound healing. J Surg Res 1996; 63: 237-40.
5. FINCH WR, RODNAN GP, BUCKINGHAM RB, PRINCE RK, WINKELSTEIN A: Bleomycin-induced scleroderma. J Rheumatol 1980; 7: 651-9.
6. KERR LD, SPIERA H: Scleroderma in association with the use of bleomycin: A report of 3 cases. J Rheumatol 1992; 19: 294-6.
7. KOVACS EJ, KELLEY J: Secretion of macrophage-derived growth factor during acute lung injury by bleomycin. J Leukocyte Biol 1985; 37: 1-14.
8. YAMAMOTO T, KATAYAMA I, NISHIOKA K: Fibroblast proliferation by bleomycin-stimulated peripheral blood mononuclear cell factors. J Rheumatol 1999; 26: 609-15.
9. SANDS WA, BULUT V, SEVERN A, XU D, LIEW FY: Inhibition of nitric oxide synthesis by interleukin-4 may involve inhibiting the activation of protein kinase C epsilon. Eur J Immunol 1994; 24: 2345-50.
10. OHNUMA T, HOLLAND JF, MASUDA H, WALIGUNDA JA, GOLDBERG GA: Microbiological assay of bleomycin: Inactivation, tissue distribution, and clearance. Cancer 1974; 33: 1230-8.
11. RADOMSKI MW, PALMER RMJ, MONCADA S: Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide, and prostacyclin platelets. BrJ Pharmacol 1987; 92: 639-46.
12. WANG R, GHAHARY A, SHEN YJ, SCOTT PG, TREDGET EE: Human dermal fibroblasts produce nitric oxide and express both constitutive and inducible nitric oxide synthase isoforms. J Invest Dermatol 1996; 106: 419-27.
13. VODOVOTZ Y, BOGDAN C, PAIK J, XIE OW, NATHAN C: Mechanisms of supression of macrophage nitric oxide release by transforming growth factor beta. J Exp Med 1993; 178: 605-13.
14. BLANCO FJ, GENG Y, LOTZ M: Differentiation-dependent effects of IL-1 and TGF-β on human articular chondrocyte proliferation are related to induce nitric oxide synthase expression. J Immunol 1995; 154: 4018-26.
15. KAHALEH MB, DELUSTRO F, BOCK W, LEROY EC: Human monocyte modulation of endothelial cells and fibroblast growth: Possible mechanism for fibrosis. Clin Immunol Immunopathol 1986; 39: 242-55.
16. NUSSLER AK, BILLIAR TR: Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukocyte Biol 1993; 54: 171-178.